Institutional Ownership Y M Abs Therapeutics, Inc. (YMAB)
This table provides information about the institutional ownership of Y M Abs Therapeutics, Inc. (YMAB). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 3.29 Million shares, which have been reported (via 13F filing form) to have a value of $28.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,938,718
shares
|
$25.3 Million
0.0% of portfolio
|
Q2 2024
Added 2.85%
|
|
|
Memorial Sloan Kettering Cancer Center
New York, NY |
Nov 14, 2023 Q3 2023 |
191,176
shares
|
$1.65 Million
4.24% of portfolio
|
Q4 2021
Reduced 11.87%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
112,483
shares
|
$968,478
0.0% of portfolio
|
Q2 2024
Reduced 57.99%
|
|
|
Ziegler Capital Management, LLC
|
May 15, 2024 Q1 2024 |
35,461
shares
|
$305,319
0.02% of portfolio
|
Q1 2024
New holding
|
|
|
Skopos Labs, Inc.
Riverhead, NY |
Nov 14, 2025 Q3 2025 |
16,061
shares
|
$138,285
0.02% of portfolio
|
Q3 2025
Added 224.4%
|
|
|
Ifp Advisors, Inc
|
Dec 02, 2025 Q3 2025 |
332
shares
|
$2,858
0.0% of portfolio
|
Q3 2025
Reduced 0.6%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|